Artificial General Intelligence (AGI) could outperform human traders in crypto markets, impacting price movements and trading strategies.

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

The headlines are the Galaxy S25 line-up, but the hardware is powered by Samsung's ambition to develop an AI ecosystem ...

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

On his second day in office, President Donald Trump unveiled a joint, private-sector venture to fund billions of dollars in U ...

As science wrestles with the thorny job of proving, defining and understanding human consciousness, one pioneering startup aims to apply cutting-edge theories of consciousness to AI models – and ...

Whether you’re an AI enthusiast or just curious about where the technology is headed, this gathering provides an open space ...

Google DeepMind Chief Operations Officer Lila Ibrahim discussed the changes that the Trump administration may bring, ...

A string of startups are racing to build models that can produce better and better software. They claim it’s the shortest path to AGI.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

The integration of reinforcement learning from human feedback with passive brain-computer interface technology presents both ...

European artificial intelligence champion Mistral AI is “not for sale” and instead is working toward an initial public offering, according to Chief Executive Officer Arthur Mensch.